Other recurrent nonsilent mutations (≥ 3 cases) were found in 24 breast cancer- or cancer-related genes including TP53 (13 cases), ATM (7 cases), CDH1 (7 cases), APC (6 cases), ERBB2 (5 cases), FGFR1 (5 cases), and MET (5 cases). This evidence concerns the gene MET and cancer.